SCHEMBL5315372

SCHEMBL5315372

CCOC(=O)n1nc(C)cc1Nc1nc(N2CC3C(C2)C3NC(C)=O)nc2ncccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 4/20 0.37
▸ HCRTR2 O43614 4/20 0.37
▸ NPSR1 Q6W5P4 8/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 5/20 0.35
▸ MAPT P10636 4/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ NR2F2 P24468 2/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 5/20 0.35
▸ LMNA P02545 4/20 0.35
▸ PPP1CA P62136 4/20 0.35
▸ TSHR P16473 4/20 0.35
▸ XBP1 P17861 2/20 0.35
▸ RAB9A P51151 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4532654 1.00 HCRTR1 (0.37) HCRTR1HCRTR2NPSR1MEN1KMT2A
SCHEMBL4511494 0.91 HCRTR1 (0.34) HCRTR1HCRTR2NPSR1MEN1KMT2A
SCHEMBL4526388 0.91 HCRTR1 (0.34) HCRTR1HCRTR2NPSR1MEN1KMT2A
SCHEMBL4526026 0.91 HCRTR2 (0.35) HCRTR1HCRTR2NPSR1MEN1KMT2A
SCHEMBL4522897 0.91 HCRTR1 (0.34) HCRTR1HCRTR2NPSR1MEN1KMT2A
SCHEMBL4511499 0.85 HCRTR1 (0.33) HCRTR1HCRTR2NPSR1MEN1KMT2A
SCHEMBL5262877 0.84 HCRTR1 (0.32) HCRTR1HCRTR2MAPTABCG2GAA
SCHEMBL5315816 0.81 CCR4 (0.32) HCRTR1HCRTR2SMN1; SMN2KDM4EMAPT
SCHEMBL4513370 0.78 ABCG2 (0.36) HCRTR1HCRTR2LTA4HABCG2
SCHEMBL4512965 0.72 AXL (0.35) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831216-A2 HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS Pfizer Products Inc. (US) 2007-09-12 — — EP disclosed
WO-2006067614-A2 HETEROAROMATIC DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER PRODUCTS INC. (US) 2006-06-29 — — WO disclosed
Send feedback